From LEKHA MUTYALA
Summary:
Revolutionizing Diabetic Foot Ulcer Care with 3D Technology
Diabetic foot ulcers (DFUs) affect 1 in 4 individuals with diabetes and contribute significantly to healthcare costs and lower limb amputations worldwide. Traditional treatments—like wound debridement, glycemic control, and surgical interventions—offer limited scalability in the face of rising diabetes prevalence. Fortunately, innovative technologies are reshaping the future of DFU management. 3D-printed antibiotic bandages from Queen’s University promise rapid healing and reduced clinical burden. Meanwhile, Indian researchers have developed custom, pressure-sensitive 3D-printed footwear to enhance balance and recovery. In surgical care, 3D-bioprinted adipose tissue has successfully prevented amputations in high-risk patients. These advancements highlight how personalized, tech-driven solutions can reduce complications, improve outcomes, and lower healthcare costs for diabetic patients. Full article
————
Lekha Mutyala is a podiatry student at Kent State University College of Podiatric Medicine (KSUCPM). In 2024, she won the 38th Annual American Podiatric Medical Writers Association (APMWA) Student Writing Competition for her paper titled “Advancements in Technology and Innovative Approaches in Diabetic Foot Ulcer Management.” This achievement earned her a $1,000 honorarium from an endowment by Dr. and Mrs. Steven Berlin to the APMA Educational Foundation .
Additionally, Mutyala was recognized as a 2024–2025 APMA Educational Foundation scholarship recipient, highlighting her academic excellence and commitment to the field of podiatric medicine